Palatin Technologies, Inc. (NASDAQ:PTN)’s share price shot up 3% during mid-day trading on Friday . The stock traded as high as $1.04 and last traded at $1.03, 50,600 shares traded hands during trading. A decline of 98% from the average session volume of 2,074,145 shares. The stock had previously closed at $1.00.
Separately, BidaskClub cut shares of Palatin Technologies from a “strong-buy” rating to a “buy” rating in a research report on Friday, June 21st.
The company’s 50-day moving average is $0.91 and its 200-day moving average is $1.09.
Palatin Technologies Company Profile (NASDAQ:PTN)
Palatin Technologies, Inc, a biopharmaceutical company, develops targeted, receptor-specific peptide therapeutics for the treatment of various diseases in the United States. The company's principal product is Bremelanotide, an as needed subcutaneous injectable peptide melanocortin receptor agonist, which is in the Phase III clinical studies for the treatment of premenopausal women with hypoactive sexual desire disorder (HSDD).
Read More: Futures Contract
Receive News & Ratings for Palatin Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Palatin Technologies and related companies with MarketBeat.com's FREE daily email newsletter.